Perinatal citalopram does not prevent the effect of prenatal stress on anxiety, depressive-like behaviour and serotonergic transmission in adult rat offspring

European Journal of Neuroscience

Volumn 43, Issue 4, 2016, Pages 590-600

  Zohar, Inbar ^a   Shoham, Shai ^a   Weinstock, Marta ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Corticotropin releasing factor type 2 receptors; Dorsal raphe nuclei; Medial prefrontal cortex; Serotonin 1A autoreceptors; Tryptophan hydroxylase

Indexed keywords

CITALOPRAM; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; SEROTONIN 1A RECEPTOR; TRYPTOPHAN HYDROXYLASE; AUTORECEPTOR; CORTICOTROPIN RELEASING FACTOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANOGENITAL DISTANCE; ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CONTROLLED STUDY; DEPRESSIVE LIKE BEHAVIOR; DORSAL RAPHE NUCLEUS; DRUG EFFECT; ELEVATED PLUS MAZE TEST; FEMALE; FORCED SWIM TEST; GABAERGIC INTERNEURON; GESTATIONAL STRESS; INTERNEURON; MALE; MEDIAL PREFRONTAL CORTEX; MOLECULAR DYNAMICS; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OUTCOME ASSESSMENT; PERINATAL DRUG EXPOSURE; PRENATAL STRESS; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SEROTONERGIC TRANSMISSION; SEROTONINERGIC SYSTEM; SEX DIFFERENCE; STRESS; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; DISEASE MODEL; DRUG EFFECTS; DRUG THERAPY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PREFRONTAL CORTEX; PREGNANCY; WISTAR RAT;

ANIMALS; ANXIETY; AUTORECEPTORS; BEHAVIOR, ANIMAL; CITALOPRAM; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; FEMALE; PREFRONTAL CORTEX; PREGNANCY; RATS, WISTAR; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; STRESS, PHYSIOLOGICAL;

EID: 84958123554     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/ejn.13150     Document Type: Article

References (59)

1. Bayer, S.A., Altman, J., Russo, R.J. & Zhang, X. (1993) Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology, 14, 83-144.
2. Beversdorf, D.Q., Manning, S.E., Hillier, A., Anderson, S.L., Nordgren, R.E., Walters, S.E., Nagaraja, H.N., Cooley, W.C., Gaelic, S.E. & Bauman, M.L. (2005) Timing of prenatal stressors and autism. J. Autism Dev. Disord., 35, 471-478.
3. Bourke, C.H., Capello, C.F., Rogers, S.M., Yu, M.L., Boss-Williams, K.A., Weiss, J.M., Stowe, Z.N. & Owens, M.J. (2013) Prenatal exposure to escitalopram and/or stress in rats, a prenatal stress model of maternal depression and its treatment. Psychopharmacology, 228, 231-241.
4. Charil, A., Laplante, D.P., Vaillancourt, C. & King, S. (2010) Prenatal stress and brain development. Brain Res. Rev., 65, 56-79.
5. Choi, M.R., Hwang, S., Park, G.M., Jung, K.H., Kim, S.H., Das, N.D. & Chai, Y.G. (2012) Effect of fluoxetine on the expression of tryptophan hydroxylase and 14-3-3 protein in the dorsal raphe nucleus and hippocampus of rat. J. Chem. Neuroanat., 43, 96-102.
6. Courtin, J., Chaudun, F., Rozeske, R.R., Karalis, N., Gonzalez-Campo, C., Wurtz, H., Abdi, A., Baufreton, J., Bienvenu, T.C. & Herry, C. (2014) Prefrontal parvalbumin interneurons shape neuronal activity to drive fear expression. Nature, 505, 92-96.
7. Day, H.E., Greenwood, B.N., Hammack, S.E., Watkins, L.R., Fleshner, M., Maier, S.F. & Campeau, S. (2004) Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J. Comp. Neurol., 474, 364-378.
8. Franssen, E.J., Meijs, V., Ettaher, F., Valerio, P.G., Keessen, M. & Lameijer, W. (2006) Citalopram serum and milk levels in mother and infant during lactation. Ther. Drug Monit., 28, 2-4.
9. Garcia-Garcia, A.L., Newman-Tancredi, A. & Leonardo, E.D. (2014) 5-HT(1A) [corrected] receptors in mood and anxiety, recent insights into autoreceptor versus heteroreceptor function. Psychopharmacology, 231, 623-636.
10. Gaspar, P., Cases, O. & Maroteaux, L. (2003) The developmental role of serotonin, news from mouse molecular genetics. Nat. Rev. Neurosci., 4, 1002-1012.
11. Giardinelli, L., Innocenti, A., Benni, L., Stefanini, M.C., Lino, G., Lunardi, C., Svelto, V., Afshar, S., Bovani, R., Castellini, G. & Faravelli, C. (2012) Depression and anxiety in perinatal period, prevalence and risk factors in an Italian sample. Arch. Womens Ment. Health, 15, 21-30.
12. Goelman, G., Ilinca, R., Zohar, I. & Weinstock, M. (2014) Functional connectivity in prenatally stressed rats with and without maternal treatment with ladostigil, a brain-selective monoamine oxidase inhibitor. Eur. J. Neurosci., 40, 2734-2743.
13. Hale, M.W., Johnson, P.L., Westerman, A.M., Abrams, J.K., Shekhar, A. & Lowry, C.A. (2010) Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala. Prog. Neuropsychopharmacol. Biol. Psychiat, 34, 1285-1293.
14. Hansson, S.R., Mezey, E. & Hoffman, B.J. (1999) Serotonin transporter messenger RNA expression in neural crest-derived structures and sensory pathways of the developing rat embryo. Neuroscience, 89, 243-265.
15. Hayes, R.M., Wu, P., Shelton, R.C., Cooper, W.O., Dupont, W.D., Mitchel, E. & Hartert, T.V. (2012) Maternal antidepressant use and adverse outcomes, a cohort study of 228, 876 pregnancies. Am. J. Obstet. Gynecol., 207, 49 e41-49 e49.
16. Hendrick, V., Stowe, Z.N., Altshuler, L.L., Hwang, S., Lee, E. & Haynes, D. (2003) Placental passage of antidepressant medications. Am. J. Psychiat, 160, 993-996.
17. Holmes, A., Yang, R.J., Lesch, K.P., Crawley, J.N. & Murphy, D.L. (2003) Mice lacking the serotonin transporter exhibit 5-HT(1A) receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology, 28, 2077-2088.
18. Husain, N., Cruickshank, K., Husain, M., Khan, S., Tomenson, B. & Rahman, A. (2012) Social stress and depression during pregnancy and in the postnatal period in British Pakistani mothers, A cohort study. J. Affect. Disorders, 140, 268-276.
19. Iritani, S., Tohgi, M., Arai, T. & Ikeda, K. (2006) Immunohistochemical study of the serotonergic neuronal system in an animal model of the mood disorder. Exp. Neurol., 201, 60-65.
20. Jensen, J.B., Jessop, D.S., Harbuz, M.S., Mork, A., Sanchez, C. & Mikkelsen, J.D. (1999) Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J. Neuroendocrinol., 11, 465-471.
21. Jordan, A.E., Jackson, G.L., Deardorff, D., Shivakumar, G., McIntire, D.D. & Dashe, J.S. (2008) Serotonin reuptake inhibitor use in pregnancy and the neonatal behavioral syndrome. J. Matern. Fetal Neonatal Med., 21, 745-751.
22. Kepser, L.J. & Homberg, J.R. (2015) The neurodevelopmental effects of serotonin, a behavioural perspective. Behav. Brain Res., 277, 3-13.
23. Kieler, H., Artama, M., Engeland, A., Ericsson, O., Furu, K., Gissler, M., Nielsen, R.B., Norgaard, M., Stephansson, O., Valdimarsdottir, U., Zoega, H. & Haglund, B. (2012) Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn, population based cohort study from the five Nordic countries. Brit. Med. J., 344, d8012.
24. Kinney, H.C., Belliveau, R.A., Trachtenberg, F.L., Rava, L.A. & Paterson, D.S. (2007) The development of the medullary serotonergic system in early human life. Auton. Neurosci., 132, 81-102.
25. Lukkes, J.L., Summers, C.H., Scholl, J.L., Renner, K.J. & Forster, G.L. (2009) Early life social isolation alters corticotropin-releasing factor responses in adult rats. Neuroscience, 158, 845-855.
26. Lukkes, J.L., Staub, D.R., Dietrich, A., Truitt, W., Neufeld-Cohen, A., Chen, A., Johnson, P.L., Shekhar, A. & Lowry, C.A. (2011) Topographical distribution of corticotropin-releasing factor type 2 receptor-like immunoreactivity in the rat dorsal raphe nucleus, co-localization with tryptophan hydroxylase. Neuroscience, 183, 47-63.
27. Maciag, D., Simpson, K.L., Coppinger, D., Lu, Y., Wang, Y., Lin, R.C. & Paul, I.A. (2006) Neonatal antidepressant exposure has lasting effects on behavior and serotonin circuitry. Neuropsychopharmacology, 31, 47-57.
28. Maes, M. & Meltzer, H.Y. (1995) The serotonin hypothesis of major depression. In Bloom, F.E. & Kupfer, D.J. (Ed.), Psychopharmacology: The Fourth Generation of Progress, Raven Press, New York, pp. 933-944.
29. Miszkurka, M., Goulet, L. & Zunzunegui, M.V. (2012) Antenatal depressive symptoms among Canadian-born and immigrant women in Quebec, differential exposure and vulnerability to contextual risk factors. Soc. Psychiatry Psychiatr. Epidemiol., 47, 1639-1648.
30. Miyagawa, K., Tsuji, M., Fujimori, K., Saito, Y. & Takeda, H. (2011) Prenatal stress induces anxiety-like behavior together with the disruption of central serotonin neurons in mice. Neurosci. Res., 70, 111-117.
31. Nagano, M., Liu, M., Inagaki, H., Kawada, T. & Suzuki, H. (2012) Early intervention with fluoxetine reverses abnormalities in the serotonergic system and behavior of rats exposed prenatally to dexamethasone. Neuropharmacology, 63, 292-300.
32. Noga, B.R., Johnson, D.M., Riesgo, M.I. & Pinzon, A. (2009) Locomotor-activated neurons of the cat. I. Serotonergic innervation and co-localization of 5-HT7, 5-HT2A, and 5-HT1A receptors in the thoraco-lumbar spinal cord. J. Neurophysiol., 102, 1560-1576.
33. Nulman, I., Koren, G., Rovet, J., Barrera, M., Pulver, A., Streiner, D. & Feldman, B. (2012) Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am. J. Psychiat, 169, 1165-1174.
34. Olivier, J.D., Valles, A., van Heesch, F., Afrasiab-Middelman, A., Roelofs, J.J., Jonkers, M., Peeters, E.J., Korte-Bouws, G.A., Dederen, J.P., Kiliaan, A.J., Martens, G.J., Schubert, D. & Homberg, J.R. (2011) Fluoxetine administration to pregnant rats increases anxiety-related behavior in the offspring. Psychopharmacology, 217, 419-432.
35. Pawluski, J.L., Charlier, T.D., Fillet, M., Houbart, V., Crispin, H.T., Steinbusch, H.W. & van den Hove, D.L. (2012) Chronic fluoxetine treatment and maternal adversity differentially alter neurobehavioral outcomes in the rat dam. Behav. Brain Res., 228, 159-168.
36. Paxinos, G., Watson, C., Pennisi, M. & Topple, A. (1985) Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J. Neurosci. Meth., 13, 139-143.
37. Pereira, O.C., Bernardi, M.M. & Gerardin, D.C. (2006) Could neonatal testosterone replacement prevent alterations induced by prenatal stress in male rats? Life Sci., 78, 2767-2771.
38. Pernar, L., Curtis, A.L., Vale, W.W., Rivier, J.E. & Valentino, R.J. (2004) Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J. Neurosci., 24, 1305-1311.
39. Porsolt, R.D., Anton, G., Blavet, N. & Jalfre, M. (1978) Behavioural despair in rats, a new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 47, 379-391.
40. Rampono, J., Simmer, K., Ilett, K.F., Hackett, L.P., Doherty, D.A., Elliot, R., Kok, C.H., Coenen, A. & Forman, T. (2009) Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry, 42, 95-100.
41. Rayen, I., van den Hove, D.L., Prickaerts, J., Steinbusch, H.W. & Pawluski, J.L. (2011) Fluoxetine during development reverses the effects of prenatal stress on depressive-like behavior and hippocampal neurogenesis in adolescence. PLoS One, 6, e24003.
42. Rayen, I., Steinbusch, H.W., Charlier, T.D. & Pawluski, J.L. (2013) Developmental fluoxetine exposure and prenatal stress alter sexual differentiation of the brain and reproductive behavior in male rat offspring. Psychoneuroendocrinology, 38, 1618-1629.
43. Real, M.A., Heredia, R., Labrador Mdel, C., Davila, J.C. & Guirado, S. (2009) Expression of somatostatin and neuropeptide Y in the embryonic, postnatal, and adult mouse amygdalar complex. J. Comp. Neurol., 513, 335-348.
44. Rubenstein, J.L. (1998) Development of serotonergic neurons and their projections. Biol. Psychiat, 44, 145-150.
45. Salisbury, A.L., Wisner, K.L., Pearlstein, T., Battle, C.L., Stroud, L. & Lester, B.M. (2011) Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress. Anxiety, 28, 1008-1019.
46. Salomon, S., Bejar, C., Schorer-Apelbaum, D. & Weinstock, M. (2011) Corticosterone mediates some but not other behavioural changes induced by prenatal stress in rats. J. Neuroendocrinol., 23, 118-128.
47. Schmidt, M.J., Horvath, S., Ebert, P., Norris, J.L., Seeley, E.H., Brown, J., Gellert, L., Everheart, M., Garbett, K.A., Grice, T.W., Caprioli, R.M. & Mirnics, K. (2014) Modulation of behavioral networks by selective interneuronal inactivation. Mol. Psychiatr, 19, 580-587.
48. Smit-Rigter, L.A., Noorlander, C.W., von Oerthel, L., Chameau, P., Smidt, M.P. & van Hooft, J.A. (2012) Prenatal fluoxetine exposure induces life-long serotonin 5-HT(3) receptor-dependent cortical abnormalities and anxiety-like behaviour. Neuropharmacology, 62, 865-870.
49. Spiga, F., Lightman, S.L., Shekhar, A. & Lowry, C.A. (2006) Injections of urocortin 1 into the basolateral amygdala induce anxiety-like behavior and c-Fos expression in brainstem serotonergic neurons. Neuroscience, 138, 1265-1276.
50. Stahl, S.M. (1998) Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J. Affect. Disorders, 51, 215-235.
51. Tan, H., Young, L.T., Shao, L., Che, Y., Honer, W.G. & Wang, J.F. (2012) Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex. Int. J. Neuropsychoph., 15, 1275-1285.
52. Thompson, M.R., Li, K.M., Clemens, K.J., Gurtman, C.G., Hunt, G.E., Cornish, J.L. & McGregor, I.S. (2004) Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. Neuropsychopharmacology, 29, 694-704.
53. Valentino, R.J., Lucki, I. & van Bockstaele, E. (2009) Corticotropin-releasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res., 1314, 29-37.
54. Wallace, J.A. & Lauder, J.M. (1983) Development of the serotonergic system in the rat embryo, an immunocytochemical study. Brain Res. Bull., 10, 459-479.
55. Weinstock, M. (2008) The long-term behavioural consequences of prenatal stress. Neurosci. Biobehav. R., 32, 1073-1086.
56. Weisskopf, E., Fischer, C.J., Bickle Graz, M., Morisod Harari, M., Tolsa, J.F., Claris, O., Vial, Y., Eap, C.B., Csajka, C. & Panchaud, A. (2015) Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence. Expert Opin. Drug Saf., 14, 413-427.
57. Whitaker-Azmitia, P.M., Druse, M., Walker, P. & Lauder, J.M. (1996) Serotonin as a developmental signal. Behav. Brain Res., 73, 19-29.
58. Zohar, I., Dosoretz-Abittan, L., Shoham, S. & Weinstock, M. (2015) Sex dependent reduction by prenatal stress of the expression of 5HT1A receptors in the prefrontal cortex and CRF type 2 receptors in the raphe nucleus in rats: reversal by citalopram. Psychopharmacology, 232, 1643-1653.
59. Zuena, A.R., Mairesse, J., Casolini, P., Cinque, C., Alema, G.S., Morley-Fletcher, S., Chiodi, V., Spagnoli, L.G., Gradini, R., Catalani, A., Nicoletti, F. & Maccari, S. (2008) Prenatal restraint stress generates two distinct behavioral and neurochemical profiles in male and female rats. PLoS One, 3, e2170.